Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions
Phase 1
- Conditions
- Bioequivalence
- Interventions
- Drug: Aviga, capsules 50 mg / Sutent®, capsules 50 mgDrug: Sutent®, capsules 50 mg / Aviga, capsules 50 mg
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2022-02-01
- Lead Sponsor
- JLLC NatiVita
- Target Recruit Count
- 22
- Registration Number
- NCT05218616
- Locations
- 🇧🇾
National Anti-Doping Laboratory, Lesnoy, Minsk Region, Belarus
News
No news found